Finance

Lists
300194:SHE
Fuan Pharmaceutical Group Co Ltd
CN¥3.91
-0.26%
(-0.0100) 1D
Oct 16, 3:04:40 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300194...
Open
CN¥3.95
High
CN¥4.02
Low
CN¥3.89
Mkt. cap
4.74B
Avg. vol.
16.02M
Volume
26.19M
Dividend
1.79%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 28, 2026
P/E ratio
77.98
52-wk high
CN¥5.00
52-wk low
CN¥3.24
EPS
CN¥0.05
Shares outstanding
1.19B
No. of employees
3K
Open
CN¥3.95
High
CN¥4.02
Low
CN¥3.89
Mkt. cap
4.74B
Avg. vol.
16.02M
Volume
26.19M
Dividend
1.79%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 28, 2026
P/E ratio
77.98
52-wk high
CN¥5.00
52-wk low
CN¥3.24
EPS
CN¥0.05
Shares outstanding
1.19B
No. of employees
3K
News stories
From web sources and news partners
About Fuan Pharmaceutical Group Co Ltd
CEO-
Employees2.99K
FoundedFeb 25, 2004
Headquarters-
SectorPharmaceutical industry
Websitefapharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
394.87M
422.92M
407.49M
431.80M
Cost of goods sold
240.79M
297.74M
242.14M
273.20M
Cost of revenue
240.79M
297.74M
242.14M
273.20M
Research and development expenses
40.41M
31.74M
26.09M
20.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
100.86M
98.27M
96.78M
85.89M
Operating expense
148.55M
124.59M
129.97M
107.26M
Total operating expenses
389.35M
422.33M
372.11M
380.45M
Operating income
5.52M
592.72K
35.38M
51.35M
Other non operating income
140.02K
-539.92K
-820.50K
197.62K
EBT including unusual items
49.47M
-84.64M
58.91M
47.01M
EBT excluding unusual items
46.95M
42.67M
53.83M
48.31M
Income tax expense
-3.66M
4.74M
4.14M
6.26M
Effective tax rate
-7.39%
-5.61%
7.02%
13.31%
Other operating expenses
10.64M
-6.54M
6.39M
849.14K
Net income
53.14M
-89.27M
54.92M
40.86M
Net profit margin
13.46%
-21.11%
13.48%
9.46%
Earnings per share
-
-
-
-
Interest and investment income
47.51M
47.48M
23.21M
1.48M
Interest expense
-5.80M
-5.06M
-3.93M
-3.67M
Net interest expenses
41.71M
42.42M
19.27M
-2.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
54.79M
51.56M
86.34M
101.01M
Gain or loss from assets sale
-35.99K
-266.14K
-
-10.30K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps